메뉴 건너뛰기
.. 내서재 .. 알림
소속 기관/학교 인증
인증하면 논문, 학술자료 등을  무료로 열람할 수 있어요.
한국대학교, 누리자동차, 시립도서관 등 나의 기관을 확인해보세요
(국내 대학 90% 이상 구독 중)
로그인 회원가입 고객센터 ENG
주제분류

추천
검색

논문 기본 정보

자료유형
학술저널
저자정보
저널정보
한국병원약사회 병원약사회지 병원약사회지 제35권 제2호
발행연도
2018.1
수록면
196 - 208 (13page)

이용수

표지
📌
연구주제
📖
연구배경
🔬
연구방법
🏆
연구결과
AI에게 요청하기
추천
검색

초록· 키워드

오류제보하기
Background : The hospitalized patients requiring parenteral nutrition (PN) often need to receive intravenous medications as well, as noted in some cases. The Y-site administration is occasionally necessary, but some physicochemical incompatibilities can occur between the medications and PN. The absence of drug compatibility information with 3-in-1 parenteral nutrition admixture (PNA) has been problematic in this case. The infusion of a precipitate or destabilized emulsion can be harmful for the patients. Therefore, the aim of this study was to evaluate the physical compatibility of 2 selected drugs during a simulated Y-site injection and additive condition into a 3-in-1 PNA. Methods : 3-in-1 PNA (OMAFONE􀋓 Inj 986 mL) were tested with two drugs (diltiazem, vasopressin). PNAs and drugs were mixed in 1:1(v/v) proportions and the compatibility was assessed at the time of mixing and after 1, 24, 48 and 72 hours. Chiefly, the assessment of potential precipitation and the emulsion stability was performed by a subvisual particle counting an, through visual examinations and a measurement of globule size distribution. Results : In all samples we did not observe changes on the visual examinations. It is noted that the oil droplet mean size changes over 1.5 μm are to exceed 2% in the Y-site samples of diltiazem and vasopressin within 24 hours. In particular, these samples of vasopressin did not disappear until after a 72 hours timeframe. However, the globule size distribution via a dynamic light scattering are maintained at 200-300 nm during the experimental period. Conclusions : The present study experiment noted the compatibility of 1 commercially available PNA and 2 medications. The extrapolation of compatibility data based on conditions applicable for other products is not recommended. It is noted that a different outcome can also be a result of differences in the methodology or interpretation of the results. Finally, we recommend that a filter is concerned primarily with the protection of patients from the effects of an infusion of particulates and chemical precipitates. The appropriate use of this complex therapy is able to maximize the clinical benefit while minimizing the potential risks for adverse events.

목차

등록된 정보가 없습니다.

참고문헌 (23)

참고문헌 신청

함께 읽어보면 좋을 논문

논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!

이 논문의 저자 정보

최근 본 자료

전체보기

댓글(0)

0